As clinical trials grow more complex, identifying the right patients and optimizing trial sites becomes increasingly critical. AstraZeneca is transforming this process with Development Assistant—a generative AI-powered agent on Amazon Web Services (AWS) that simplifies access to clinical data and drives greater operational efficiencies.

Development Assistant enables operation teams to query both structured and unstructured data using natural language, delivering real-time, evidence-based insights in seconds. Built on Amazon Bedrock with integrated retrieval-augmented generation (RAG) and text-to-SQL capabilities, this platform surfaces insights from AstraZeneca's extensive data landscape while providing traceable source information that brings transparency.

Key points covered:

• Accelerated innovation: Streamlined trial design and automated processes that compress development timelines by addressing critical challenges like patient recruitment and site selection.

• Enhanced data accessibility: Natural language queries across diverse systems fuel scalable, multimodal AI applications. 

• Scalability and agility: Multi-agent architecture supports scalability and agility, designed to handle increasing user demand and data complexity. 

Discover how AstraZeneca is using Amazon Bedrock to accelerate clinical trials — get inspired to boost your organization’s breakthrough capabilities with AWS.